These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28121260)

  • 1. Treatment of Agitation in Huntington's Disease With Electroconvulsive Therapy.
    Shah RP; Alluri V; Sharma S
    J Neuropsychiatry Clin Neurosci; 2017; 29(3):293-294. PubMed ID: 28121260
    [No Abstract]   [Full Text] [Related]  

  • 2. ECT for the treatment of Huntington's disease: a case study.
    Beale MD; Kellner CH; Gurecki P; Pritchett JT
    Convuls Ther; 1997 Jun; 13(2):108-12. PubMed ID: 9253530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease.
    Rej S; Desautels R
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E33-4. PubMed ID: 24026736
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of agitation and aggression in four demented patients using ECT.
    Grant JE; Mohan SN
    J ECT; 2001 Sep; 17(3):205-9. PubMed ID: 11528314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive Therapy (ECT) for Refractory Psychiatric Symptoms in Huntington's Disease: A Case Series and Review of the Literature.
    Adrissi J; Nadkarni NA; Gausche E; Bega D
    J Huntingtons Dis; 2019; 8(3):291-300. PubMed ID: 31322579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECT as a treatment for depression in Huntington's disease.
    Ranen NG; Peyser CE; Folstein SE
    J Neuropsychiatry Clin Neurosci; 1994; 6(2):154-9. PubMed ID: 8044037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option.
    Glass OM; Forester BP; Hermida AP
    Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Response to ECT of Psychotic and Affective Symptoms in Huntington's Disease: A Case Report.
    Petit AC; Hozer F; Youssov K; Lavaud P; Hardy P; Mouaffak F
    J Neuropsychiatry Clin Neurosci; 2016; 28(1):e3-5. PubMed ID: 26844968
    [No Abstract]   [Full Text] [Related]  

  • 11. Electroconvulsive Therapy for Agitation and Aggression in Dementia: A Systematic Review.
    van den Berg JF; Kruithof HC; Kok RM; Verwijk E; Spaans HP
    Am J Geriatr Psychiatry; 2018 Apr; 26(4):419-434. PubMed ID: 29107460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
    Bryson EO; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECT as a form of restraint.
    Can J Psychiatry; 1984 Jun; 29(4):369. PubMed ID: 6733672
    [No Abstract]   [Full Text] [Related]  

  • 16. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
    Correll CU; Yu X; Xiang Y; Kane JM; Masand P
    Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
    Narang P; Ianovich F; Sarai SK; Lippmann S
    J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agitated depression successfully treated with electroconvulsive therapy combined with steroid cover in a patient with Addison's disease.
    Suzuki K; Awata S; Oyama Y; Fujiyama M; Takano T; Sugawara A; Matsuoka H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):956-8. PubMed ID: 17324493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid improvement of depression and psychotic symptoms in Huntington's disease: a retrospective chart review of seven patients treated with electroconvulsive therapy.
    Cusin C; Franco FB; Fernandez-Robles C; DuBois CM; Welch CA
    Gen Hosp Psychiatry; 2013; 35(6):678.e3-5. PubMed ID: 23541803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.